Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

‘Angel investors bring more than money’ – Interview with PBD Biotech CEO

Following PBD Biotech’s successful seed funding round, CEO Dr Berwyn Clarke spoke to Growth Business, the leading media portal for entrepreneurs, about the start-up’s strategic approach to securing the right investment for phage-based technology.
  • August 7, 2018
  • Company
  • interview, investment
Dr Berwyn Clarke at REAP
Dr Berwyn Clarke at Agri-Tech East's REAP conference

Commenting on the £400,000 that was secured from angel investment, alongside other sources, Dr Clarke said: “Angel investment was chosen as a successful route for PBD Biotech’s specialised products. This was because of the specialist local networks of individuals knowledgeable about the industry, and who understood the international opportunity offered by the technology.

“There is an enormous need for a tool to better monitor and control TB and M. paratuberculosis infections in livestock and other animals, and as such there is an enormous value attachment for an accurate test like Actiphage®. In England alone, bovine TB costs taxpayers over £100 million every year.”

To read the full interview about PBD Biotech, please visit growthbusiness.co.uk

Share:

Related posts

Loading...
Actiphage

PBD Biotech gains attention of East of England Investment Catalyst among other investors

October 7, 2019
TB in humans and animals is a huge global problem as there is a lack of rapid, accurate ways to detect the disease at an early stage. PBD Biotech has developed Actiphage®, a new sensitive test that can detect the...
Actiphage

PBD Biotech gains attention of East of England Investment Catalyst among other investors

October 7, 2019
TB in humans and animals is a huge global problem as there is a lack of rapid, accurate ways to...
Blood test

International demand for first sensitive test for mycobacteria in blood or milk

August 15, 2018
Bovine TB is one of a group of diseases caused by mycobacteria that has devastated the agricultural industry worldwide. Now UK agri-tech start-up PBD Biotech, developers of the first rapid test for live mycobacteria, has secured £400,000 in its first...
Blood test

International demand for first sensitive test for mycobacteria in blood or milk

August 15, 2018
Bovine TB is one of a group of diseases caused by mycobacteria that has devastated the agricultural industry worldwide. Now...
New Anglia LEP CEO Chris Starkie and PBD Biotech CEO Berwyn Clarke

PBD Biotech gains funding to fuel overseas expansion

June 27, 2018
To meet the growing international demand for its rapid, sensitive test for mycobacterial disease, PBD Biotech is to establish a Canadian subsidiary in Saskatoon to support its first overseas commercial activity.
New Anglia LEP CEO Chris Starkie and PBD Biotech CEO Berwyn Clarke

PBD Biotech gains funding to fuel overseas expansion

June 27, 2018
To meet the growing international demand for its rapid, sensitive test for mycobacterial disease, PBD Biotech is to establish a...
Eastern Agri-Tech Innovation Fund

PBD Biotech award grant to support rapid, accurate, diagnosis of bacterial infection in animals

June 7, 2017
PBD Biotech Ltd has received a grant of £60,000 from the Greater Cambridge Greater Peterborough LEP’s Eastern Agri-Tech Growth Initiative to support its innovative technology for rapid, accurate and sensitive diagnosis of bacterial infection in animals.
Eastern Agri-Tech Innovation Fund

PBD Biotech award grant to support rapid, accurate, diagnosis of bacterial infection in animals

June 7, 2017
PBD Biotech Ltd has received a grant of £60,000 from the Greater Cambridge Greater Peterborough LEP’s Eastern Agri-Tech Growth Initiative...

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More